Cardiac Na+-Ca2+ exchanger 1 (ncx1h) is critical for the ventricular cardiomyocyte formation via regulating the expression levels of gata4 and hand2 in zebrafish

被引:0
|
作者
Liming Chu
Huimin Yin
Lei Gao
Li Gao
Yu Xia
Chiyuan Zhang
Yi Chen
Tingxi Liu
Jijun Huang
Kenneth R. Boheler
Yong Zhou
Huang-Tian Yang
机构
[1] University of Chinese Academy of Sciences (CAS),CAS Key Laboratory of Tissue Microenvironment and Tumor, Laboratory of Molecular Cardiology and Laboratory of Development and Diseases, Shanghai Institute of Nutrition and Health
[2] CAS,State Key Laboratory for Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital
[3] Institute for Stem Cell and Regeneration,Department of Biomedical Engineering
[4] CAS,undefined
[5] Shanghai Jiao Tong University School of Medicine,undefined
[6] The Johns Hopkins University,undefined
来源
关键词
Ca; transport protein; ventricular cardiomyocyte formation; zebrafish;
D O I
暂无
中图分类号
学科分类号
摘要
Ca2+ signaling is critical for heart development; however, the precise roles and regulatory pathways of Ca2+ transport proteins in cardiogenesis remain largely unknown. Sodium-calcium exchanger 1 (Ncx1) is responsible for Ca2+ efflux in cardiomyocytes. It is involved in cardiogenesis, while the mechanism is unclear. Here, using the forward genetic screening in zebrafish, we identified a novel mutation at a highly-conserved leucine residue in ncx1 gene (mutantLDD353/ncx1hL154P) that led to smaller hearts with reduced heart rate and weak contraction. Mechanistically, the number of ventricular but not atrial cardiomyocytes was reduced in ncx1hL154P zebrafish. These defects were mimicked by knockdown or knockout of ncx1h. Moreover, ncx1hL154P had cytosolic and mitochondrial Ca2+ overloading and Ca2+ transient suppression in cardiomyocytes. Furthermore, ncx1hL154P and ncx1h morphants downregulated cardiac transcription factors hand2 and gata4 in the cardiac regions, while overexpression of hand2 and gata4 partially rescued cardiac defects including the number of ventricular myocytes. These findings demonstrate an essential role of the novel 154th leucine residue in the maintenance of Ncx1 function in zebrafish, and reveal previous unrecognized critical roles of the 154th leucine residue and Ncx1 in the formation of ventricular cardiomyocytes by at least partially regulating the expression levels of gata4 and hand2.
引用
收藏
页码:255 / 268
页数:13
相关论文
共 24 条
  • [21] Cardiac-specific expression and hypertrophic upregulation of the feline Na+-Ca2+ exchanger gene H1-promoter in a transgenic mouse model
    Müller, JG
    Isomatsu, Y
    Koushik, SV
    O'Quinn, M
    Xu, L
    Kappler, CS
    Hapke, E
    Zile, MR
    Conway, SJ
    Menick, DR
    CIRCULATION RESEARCH, 2002, 90 (02) : 158 - 164
  • [22] Transport activity and surface expression of the Na+-Ca2+ exchanger NCX1 are inhibited by the immunosuppressive agent cyclosporin A and by the nonimmunosuppressive agent PSC833
    Kimchi-Sarfaty, C
    Kasir, J
    Ambudkar, SV
    Rahamimoff, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (04) : 2505 - 2510
  • [23] GATA3 (GATA-Binding Protein 3)/KMT2A (Lysine-Methyltransferase-2A) Complex by Increasing H3K4-3me (Trimethylated Lysine-4 of Histone-3) Upregulates NCX3 (Na+-Ca2+ Exchanger 3) Transcription and Contributes to Ischemic Preconditioning Neuroprotection
    Guida, Natascia
    Mascolo, Luigi
    Serani, Angelo
    Cuomo, Ornella
    Anzilotti, Serenella
    Brancaccio, Paola
    Pignataro, Giuseppe
    Molinaro, Pasquale
    Annunziato, Lucio
    Formisano, Luigi
    STROKE, 2021, 52 (11) : 3680 - 3691
  • [24] Molecular Pharmacology of the Amiloride Analog 3-Amino-6-chloro-5-[(4-chloro-benzyl)amino]-N-[[(2,4-dimethylbenzyl)amino]iminomethyl]-pyrazinecarboxamide (CB-DMB) as a Pan Inhibitor of the Na+-Ca2+ Exchanger Isoforms NCX1, NCX2, and NCX3 in Stably Transfected Cells
    Secondo, Agnese
    Pannaccione, Anna
    Molinaro, Pasquale
    Ambrosino, Paolo
    Lippiello, Pellegrino
    Esposito, Alba
    Cantile, Maria
    Khatri, Priti R.
    Melisi, Daniela
    Di Renzo, Gianfranco
    Annunziato, Lucio
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (01): : 212 - 221